Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
29.70
-0.74 (-2.43%)
At close: Dec 20, 2024, 4:00 PM
30.00
+0.30 (1.01%)
After-hours: Dec 20, 2024, 7:47 PM EST
Collegium Pharmaceutical Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for COLL stock have an average target of 42, with a low estimate of 37 and a high estimate of 50. The average target predicts an increase of 41.41% from the current stock price of 29.70.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 11, 2024.
Analyst Ratings
The average analyst rating for COLL stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Reiterates $37 | Hold | Reiterates | $37 | +24.58% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $50 | Strong Buy | Maintains | $47 → $50 | +68.35% | Sep 5, 2024 |
| Piper Sandler | Piper Sandler | Hold Reiterates $39 → $37 | Hold | Reiterates | $39 → $37 | +24.58% | Aug 9, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $40 → $42 | Strong Buy | Maintains | $40 → $42 | +41.41% | Aug 9, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 9, 2024 |
Financial Forecast
Revenue This Year
641.56M
from 566.77M
Increased by 13.20%
Revenue Next Year
754.65M
from 641.56M
Increased by 17.63%
EPS This Year
6.29
from 1.29
Increased by 386.07%
EPS Next Year
6.71
from 6.29
Increased by 6.73%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 663.8M | 804.2M | 872.2M | ||
| Avg | 641.6M | 754.7M | 775.4M | ||
| Low | 614.0M | 699.0M | 697.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.1% | 25.4% | 15.6% | ||
| Avg | 13.2% | 17.6% | 2.8% | ||
| Low | 8.3% | 9.0% | -7.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 6.58 | 7.37 | 8.19 | |
| Avg | 6.29 | 6.71 | 7.23 | |
| Low | 5.95 | 6.05 | 6.50 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 409.1% | 17.3% | 22.1% | |
| Avg | 386.1% | 6.7% | 7.7% | |
| Low | 360.1% | -3.8% | -3.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.